AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$ २९.६८
arrow_downward
-०.७०%(-०.२१) 1D
US$ २९.६८
०.००% (०.००)
bedtimeAfter hours
Closed: नोभेम्बर १८, १६:००:०१ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
US$ २९.५७
High
US$ ३०.४८
Low
US$ २९.२२
Mkt. cap
१.७८ अरब
Avg. vol.
१२.१३ लाख
Volume
०.००
52-wk high
US$ ४४.०७
52-wk low
US$ २२.२४
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
Open
US$ २९.५७
High
US$ ३०.४८
Low
US$ २९.२२
Mkt. cap
१.७८ अरब
Avg. vol.
१२.१३ लाख
Volume
०.००
52-wk high
US$ ४४.०७
52-wk low
US$ २२.२४
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
News stories
From web sources and news partners
Barron's
·
३३ मिनेट पहिले
Sell the S&P 500 Because the AI Bubble Is About to Burst, Analyst Says. Buy This Instead.
BigGo Finance
·
१ घण्टा पहिले
UBS 2027 Outlook: S&P 500 Base Case at 8,200; AI Capex Stall Could Drag It to 5,500
TradingView
·
२ घण्टा पहिले
Stock Market Today: Dow, S&P 500 Futures Rise as Wall Street Awaits Anthropic's Listing— PANW, NTES, SLS in Focus
JournalArta
·
२७ मिनेट पहिले
Stock Market Today: Nasdaq and S&P 500 Futures Rise Ahead of Anthropic Debut
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc